American Century Companies’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

American Century Companies’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,048	Closed	-$219K	–	2485
2022 Q2	$219K	Hold	6,048	–	–	﹤0.01%	2132
2022 Q1	$262K	Buy	6,048 +1,043	+21%	+$48.7K	﹤0.01%	2108
2021 Q4	$251K	Buy	5,005 +494	+11%	+$27.7K	﹤0.01%	2139
2021 Q3	$287K	Buy	4,511 +1,429	+46%	+$98.9K	﹤0.01%	2101
2021 Q2	$222K	Buy	+3,082	New	+$226K	﹤0.01%	2167
2018 Q4	–	Sell	-10,495	Closed	-$1.03M	–	1364
2018 Q3	$1.03M	Buy	+10,495	New	+$1.14M	﹤0.01%	1103

Other funds holding TARO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies's TARO Position: Q3 2022 in Review

American Century Companies sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2022, closing a stake of 6,048 shares — an estimated $219K sold.

American Century Companies first reported a position in TARO in Q3 2018 and held it in 6 quarters. The position peaked at $1.03M in Q3 2018. 71 funds tracked by Wall St. Rank hold TARO as of Q3 2022.

American Century Companies reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2022 after selling out during the quarter.
American Century Companies sold 6,048 Taro Pharmaceutical Industries Ltd. shares in Q3 2022, an estimated $219K.
American Century Companies first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2018 and held it in 6 quarters.
American Century Companies's Taro Pharmaceutical Industries Ltd. position peaked at $1.03M in Q3 2018.
71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2022.

Based on American Century Companies's 13F filing for Q3 2022, filed 14 Nov 2022.